The new OTC bronchodilator Asthmanefrin (racepinephrine) will be promoted as an alternative to Primatene Mist (epinephrine)

October 2012

The new OTC bronchodilator Asthmanefrin (racepinephrine) will be promoted as an alternative to Primatene Mist (epinephrine).

Asthmanefrin inhaler doesn't contain chlorofluorocarbons...the propellant that led to Primatene Mist's removal about a year ago.

Instead, it's a battery-powered atomizer that creates a mist of racemic epinephrine for inhalation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Hypertension debate about when to start drugs in patients with MILD hypertension
STIs Oral cefixime is no longer first-line for gonorrhea
Diabetes you'll hear MORE controversy about using pioglitazone (Actos) for type 2 diabetes
Infectious Diseases This will be the worst year yet for West Nile virus
Vaccines New virus strains in the 2012-2013 influenza vaccine
Statins whether statins increase the risk of cataracts
Overactive Bladder Myrbetriq (meer-BEH-trick, mirabegron) for overactive bladder
Respiratory & Allergy The new OTC bronchodilator Asthmanefrin (racepinephrine) will be promoted as an alternative to Primatene Mist (epinephrine)
Respiratory & Allergy whether inhaled corticosteroids inhibit growth in kids or increase fracture risk in seniors
Antipsychotics whether it makes sense to use more than one antipsychotic for schizophrenia
Depression more emphasis on treating depression in cardiac patients
Substance Use Disorder Patients are abusing Suboxone (buprenorphine/naloxone) tabs
Hepatitis C hepatitis C testing for ALL baby boomers